ILMN
ILLUMINA, INC.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$239.62
−2.27%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$249.13
From 52W high−2.27%
Volume26.89M
Market cap$36.18B
P/E (TTM)44.3x
P/S (TTM)8.1x
Div yield—
Key dataSep 18, 2026
Open
$249.13
From 52W high
−2.27%
Volume
26.89M
Market cap
$36.18B
ValuationView details →
P/E (Fwd)
42.0x
EV/EBITDA
27.5x
P/E (TTM)
44.3x
RSI (14)
67.0
MomentumView details →
1D Return
−2.27%
YTD Return
+83.94%
SummaryUpdated Jun 1, 2026
Illumina, Inc. (NASDAQ:ILMN) is a leading biotechnology company founded in 1998 and based in San Diego, California, that went public in 2000. The company pioneered the development of DNA sequencing and array-based solutions that have revolutionized genetic and genomic analysis. Over its 25+ year history, Illumina has established itself as the dominant player in the DNA sequencing market, providing the foundational technology that enables genomic research, clinical diagnostics, and personalized medicine applications worldwide.
Similar companies
Latest newsMore news →
Beijing is finalising a delegation of Chinese business leaders, potentially including BYD, Xiaomi, CATL, Gotion, Hisense, Wanxiang Group, Bank of China and COFCO Group, to join President Xi Jinping's upcoming visit to Washington, with final invitations to be sent in the coming days.2d agoBloom Energy, Illumina, and Everpure are set to be added to the S&P 500 index.16d ago